We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZBAO:NASDAQZhibao Technology Inc. Analysis

Data as of 2026-05-12 - not real-time

$0.77

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Zhibao Technology posted a ~41% revenue surge, signaling that its top‑line growth strategy is gaining traction despite a negative profit margin and a loss per share. The stock trades around $0.77 while a discounted cash‑flow model suggests a fair value near $55, implying a massive valuation gap. Technicals remain weak: the 20‑day SMA sits below both the 50‑day and 200‑day averages, confirming a bearish price trend, and the price is still below the recent resistance level of $1.19. However, the MACD has just crossed into bullish territory and the RSI hovers around the 50‑point neutral zone, hinting at a possible short‑term bounce. Volume is on an upward trajectory, which could support a breakout if buyer sentiment improves. At the same time, the stock exhibits extreme 30‑day volatility (>125%) and a modest beta, suggesting price swings are driven more by company‑specific factors than market moves.
Investors should weigh the stark valuation upside against the company's high debt load, negative operating cash flow, and regulatory exposure in China. The current support around $0.58 offers a floor, but the path to the DCF target requires a sustained turnaround in profitability and cash generation. A cautious stance is warranted in the near term, while the long‑run upside remains compelling if the firm can convert revenue growth into positive earnings and manage its balance sheet.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish technical trend with SMA hierarchy
  • proximity to recent support level
  • elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • robust revenue growth exceeding 40%
  • DCF‑derived valuation gap
  • increasing trading volume indicating accumulating interest

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • potential market share expansion in China's digital insurance space
  • long‑run tailwinds for fintech and insurance brokerage
  • significant undervaluation relative to intrinsic fair value

Key Metrics & Analysis

Financial Health

Revenue Growth40.70%
Profit Margin-19.52%
ROE-99.67%
ROA-11.02%
Debt/Equity111.55
P/B Ratio8.8
Op. Cash Flow$-107109984
Free Cash Flow$52.5M
Industry P/E16.5

Technical Analysis

TrendBearish
RSI52.1
Support$0.58
Resistance$1.19
MA 20$0.77
MA 50$0.82
MA 200$0.93
MACDBullish
VolumeIncreasing
Fear & Greed Index87.98

Valuation

Fair Value$55.66
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.05
Volatility125.15%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.